You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN, June 17, 2020 /PRNewswire/ -- The "Infection Prevention & Control - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering. The Global Infection Prevention & Control market accounted for $139.59 billion in 2018 and is expected to reach $224.08 billion by 2027 growing at a CAGR of 5.4% during the forecast period. Some of the key factors propelling the market growth include increased adoption of contract sterilization and in-house sterilization procedures, increase in incidence of hospital acquired infections (HAIS), growing number of surgical procedures, rising number of government initiatives, and rapidly growing geriatric population. However, low level of vaccination among healthcare workers is likely to hamper the market.Infection prevention and control is the most important and significant step in the development and maintenance of products in the medical devices, pharmaceuticals, and food industries. It is to prevent the transmission of communicable disease. For the prevention of any infection one should have the basic understanding of the infection and the risk of the infection. Infection prevention and control system includes the necessary products to prevent the cross infection from equipment, surface and skin of patient and healthcare staff.By products & services equipment, the personal protective equipment segment is anticipated to grow at a significant rate during the forecast period. With the growth in prevention and control concerns of various health associated infections, personal protective equipment's. To control various types of cross-infections in hospitals and clinics also there has been a growth of personal protective equipment's market globally. Demand for better quality care in hospitals and other healthcare establishments is forcing the hospitals to invest in quality medical protective wear and other accessories has also acted as a key factor in the growth of this segment.On the basis of geography, North America region is anticipated to have considerable market growth during the forecast period, due to rising prevalence of the nosocomial infection and stringent regulation followed by the hospitals, clinicians and care givers aligning with regulatory bodies. With the increase in the number of death due to Antibiotic-resistant infections, by contrast it is anticipated that there will be a growth in IP&C Market in the regions of North America.Some of the key players in infection prevention & control market include Danaher Corporation, Johnson & Johnson, Becton, Dickinson, and Company, 3M Company, Baxter International, Ansell Limited, Belimed AG, Aquionics, Bemis Company Incorporated, Abbott, Braun (B.) Melsungen AG, Cantel Medical Corporation, Cardinal Health Incorporated, Covidien, Henkel, Simens, Getinge Group, Hollister, Medtronics, and CCP Industries.What our report offers: Market share assessments for the regional and country-level segments Strategic recommendations for the new entrants Covers Market data for the years 2017, 2018, 2019, 2023 and 2027 Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc. Strategic recommendations in key business segments based on the market estimations Competitive landscaping mapping the key common trends Company profiling with detailed strategies, financials, and recent developments Supply chain trends mapping the latest technological advancements Key Topics Covered: 1 Executive Summary 2 Preface2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining2.4.2 Data Analysis2.4.3 Data Validation2.4.4 Research Approach2.5 Research Sources 2.5.1 Primary Research Sources2.5.2 Secondary Research Sources2.5.3 Assumptions3 Market Trend Analysis3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 End User Analysis 3.7 Emerging Markets 3.8 Impact of Covid-194 Porters Five Force Analysis4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Infection Prevention & Control Market, By Antimicrobial Drugs5.1 Introduction 5.2 Anti-Fungal Drugs 5.3 Vaccines 5.4 Anti-Bacterial Drugs 5.5 Anti-Viral Drugs 6 Global Infection Prevention & Control Market, By Infection Type6.1 Introduction 6.2 Healthcare Associated Infections 6.2.1 Community Acquired Infection6.2.1.1 Community Acquired Pneumonia (CAP) 6.2.1.2 Methicillin Resistant Staphylococcus Aureus (MRSA) Infection 6.2.2 Hospital Acquired Infection6.2.2.1 Surgical Site Infection6.2.2.2 Ventilator Associated Pneumonia (VAP) Infection 6.2.2.3 Central Line Associated Bloodstream Infection (CLABSI) 6.2.2.4 Catheter Associated Urinary Tract Infection 6.3 Microbial infections 6.3.1 Fungal Infections6.3.1.1 Cryptococcus Gatti 6.3.1.2 Aspergillis 6.3.1.3 Pneumocystis Pneumonia (PCP) 6.3.1.4 Dermatophytes 6.3.1.5 Gungal Keratitis 6.3.1.6 Exserohilum 6.3.1.7 Cladosporium 6.3.2 Viral Infections6.3.2.1 Herpes Simplex Virus 6.3.2.2 Yellow Fever 6.3.2.3 Dengue Viruses 6.3.2.4 Ebola Virus 6.3.2.5 Junin Virus 6.3.2.6 KFD (Kyasanur Forest Virus) 6.3.2.7 Machupo Virus 6.3.2.8 Human Immunodeficiency Virus (HIV) 6.3.3 Clostridium Difficile Infections6.3.3.1 Escherichia Coli Infections 6.3.3.2 Helicobacter Pylori 6.3.3.3 Salmonella 6.3.4 Exserohilum6.3.5 Bacterial Infections6.3.5.1 Mycobacterium Tuberculosis 7 Global Infection Prevention & Control Market, By Products & Services Equipment7.1 Introduction 7.2 Infection Prevention Supplies 7.2.1 Disinfectants7.2.1.1 Surgical Disinfectants 7.2.1.2 Environmental Disinfectants 7.2.1.3 Surface Disinfectants 7.2.1.4 Instrument Disinfectants 7.2.1.5 Skin Disinfectants 7.2.1.6 Hand Sanitizers 7.2.1.7 Disinfectants Wipes 7.2.2 Autoclave7.2.2.1 Horizontal Autoclave 7.2.2.2 Portable Autoclave 7.2.2.3 Vertical Autoclave 7.2.3 Personal Protective Equipment7.2.3.1 Medical & Laboratory Gloves 7.2.3.1.1 Examination Gloves 7.2.3.1.2 Surgical Gloves 7.2.3.1.3 Laboratory Gloves 7.2.3.2 Surgical Masks & Respirators 7.2.3.3 Surgical Foot Covers7.2.3.4 Surgical Drapes 7.2.3.4.1 Nonwoven Drapes 7.2.3.4.2 Plastic Drapes 7.2.3.4.3 Woven Drapes 7.2.3.5 Surgical Gowns 7.2.3.6 Patient Gowns 7.2.3.7 Surgical & Staff Face Masks 7.2.3.8 Other Personal Protective Equipment 7.2.3.8.1 Disposable Staff Apparel 7.2.3.8.2 Disposable Towels & Bedding 7.2.4 Safety-Enhanced Medical Devices7.2.4.1 Safety-Enhanced Syringes 7.2.4.1.1 Prefillable Syringes 7.2.4.1.2 Safety-Enhanced Clinical Syringes 7.2.4.2 Safety-Enhanced Catheters 7.2.4.2.1 IV Catheters 7.2.4.2.2 Urinary Catheters 7.2.4.3 Safety-Enhanced Blood Collection Tubes 7.2.5 Sterilization Supplies7.2.5.1 Sterile Containers 7.2.5.2 Sterilization Wrap 7.2.5.3 Sterilization Indicators 7.2.6 Medical Waste Disposal Supplies7.2.6.1 Medical Waste Disposal Containers 7.2.6.2 Medical Waste Disposal Accessories 7.3 Infection Prevention Equipment 7.3.1 Sterilization Equipment7.3.1.1 Sterilization Technologies 7.3.1.1.1 Filtration Sterilization 7.3.1.1.2 Radiation Sterilization 7.3.1.1.3 Low Temperature Sterilization 7.3.1.1.3.1 In-House Steam Sterilization7.3.1.1.3.2 Ethylene Oxide (EO) Sterilization7.3.1.1.3.3 Gamma and e-Beam Sterilization7.3.1.1.4 Wet/Stream Sterilization 7.3.1.1.5 Dry Heat Sterilization 7.3.1.1.6 Contract Sterilization Services 7.3.2 Washing/Disinfecting Equipment7.3.3 Endoscope Reprocessors7.3.4 Other Infection Prevention Equipment7.3.4.1 Infectious Waste Receptacles 7.3.4.2 Infectious Waste Processing Units 8 Global Infection Prevention & Control Market, By End User8.1 Introduction 8.2 Drug Usage 8.2.1 Individuals & Patients8.2.2 Nursing & Senior care Centers8.3 Equipment Usage 8.3.1 Medical Laboratories8.3.2 Manufacturing Units8.3.2.1 Pharmaceuticals 8.3.2.2 Medical Devices 8.3.2.3 Food & Beverages Industry 8.3.3 Hospitals & Clinics8.3.4 Life Science Industry9 Global Infection Prevention & Control Market, By Geography9.1 Introduction 9.2 North America 9.2.1 US9.2.2 Canada9.2.3 Mexico9.3 Europe 9.3.1 Germany9.3.2 UK9.3.3 Italy9.3.4 France9.3.5 Spain9.3.6 Rest of Europe9.4 Asia Pacific 9.4.1 Japan9.4.2 China9.4.3 India9.4.4 Australia9.4.5 New Zealand9.4.6 South Korea9.4.7 Rest of Asia Pacific9.5 South America 9.5.1 Argentina9.5.2 Brazil9.5.3 Chile9.5.4 Rest of South America9.6 Middle East & Africa 9.6.1 Saudi Arabia9.6.2 UAE9.6.3 Qatar9.6.4 South Africa9.6.5 Rest of Middle East & Africa10 Key Developments10.1 Agreements, Partnerships, Collaborations and Joint Ventures 10.2 Acquisitions & Mergers 10.3 New Product Launch 10.4 Expansions 10.5 Other Key Strategies 11 Company Profiling11.1 Danaher Corporation 11.2 Johnson & Johnson 11.3 Becton, Dickinson, and Company 11.4 3M Company 11.5 Baxter International 11.6 Ansell Limited 11.7 Belimed AG 11.8 Aquionics 11.9 Bemis Company Incorporated 11.10 Abbott 11.11 Braun (B.) Melsungen AG 11.12 Cantel Medical Corporation 11.13 Cardinal Health Incorporated 11.14 Covidien 11.15 Henkel 11.16 Simens 11.17 Getinge Group 11.18 Hollister 11.19 Medtronics 11.20 CCP Industries For more information about this report visit https://www.researchandmarkets.com/r/aulmz9 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Answer: $200+ Billion Worldwide Infection Prevention & Control Market to 20207 - Impact of COVID-19